Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Narod

Showing results (281-290 of 544) with videos related to

Pageof 55
Sort By:
British Journal of Cancer|March 30, 2018
The effect of selection and referral biases for the treatment of localised prostate cancer with surgery or radiationChristopher J D Wallis, Gerard Morton, Sender Herschorn, et al.
British Journal of Cancer|February 7, 2019
Oestrogen receptor status and survival in women with BRCA2-associated breast cancerKelly Metcalfe, Henry T Lynch, William D Foulkes, et al.
The Lancet. Oncology|May 2, 2006
Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control studySteven A Narod, Jan Lubinski, Parviz Ghadirian, et al.
Breast Cancer Research and Treatment|January 10, 2021
Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriersNeda Stjepanovic, Jan Lubinski, Pal Moller, et al.
BMJ (Clinical Research Ed.)|February 13, 2014
Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysisKelly Metcalfe, Shelley Gershman, Parviz Ghadirian, et al.
BMC Cancer|August 31, 2021
Genetic predisposition to male breast cancer in PolandMarek Szwiec, Joanna Tomiczek-Szwiec, Wojciech Kluźniak, et al.
Cancers|February 26, 2025
<i>BRCA1</i> and <i>BRCA2</i> Mutations in Polish Women with Ductal Carcinoma In SituSylwia Feszak, Igor Jarosław Feszak, Wojciech Kluźniak, et al.
Cancer Causes & Control : CCC|April 22, 2018
Serum osteoprotegerin levels and mammographic density among high-risk womenOlivia Moran, Tasnim Zaman, Andrea Eisen, et al.
Breast Cancer Research and Treatment|September 28, 2011
The BRCA2 c.9004G>A (E2002K) [corrected] variant is likely pathogenic and recurs in breast and/or ovarian cancer families of French Canadian descentStephanie Cote, Suzanna L Arcand, Robert Royer, et al.
The Canadian Journal of Urology|May 5, 2006
Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancerRobert K Nam, Ants Toi, Laurence H Klotz, et al.
Pageof 55

Showing results (281-290 of 544) with videos related to

Sort By:
Pageof 55
British Journal of Cancer|March 30, 2018
The effect of selection and referral biases for the treatment of localised prostate cancer with surgery or radiationChristopher J D Wallis, Gerard Morton, Sender Herschorn, et al.
British Journal of Cancer|February 7, 2019
Oestrogen receptor status and survival in women with BRCA2-associated breast cancerKelly Metcalfe, Henry T Lynch, William D Foulkes, et al.
The Lancet. Oncology|May 2, 2006
Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control studySteven A Narod, Jan Lubinski, Parviz Ghadirian, et al.
Breast Cancer Research and Treatment|January 10, 2021
Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriersNeda Stjepanovic, Jan Lubinski, Pal Moller, et al.
BMJ (Clinical Research Ed.)|February 13, 2014
Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysisKelly Metcalfe, Shelley Gershman, Parviz Ghadirian, et al.
BMC Cancer|August 31, 2021
Genetic predisposition to male breast cancer in PolandMarek Szwiec, Joanna Tomiczek-Szwiec, Wojciech Kluźniak, et al.
Cancers|February 26, 2025
<i>BRCA1</i> and <i>BRCA2</i> Mutations in Polish Women with Ductal Carcinoma In SituSylwia Feszak, Igor Jarosław Feszak, Wojciech Kluźniak, et al.
Cancer Causes & Control : CCC|April 22, 2018
Serum osteoprotegerin levels and mammographic density among high-risk womenOlivia Moran, Tasnim Zaman, Andrea Eisen, et al.
Breast Cancer Research and Treatment|September 28, 2011
The BRCA2 c.9004G>A (E2002K) [corrected] variant is likely pathogenic and recurs in breast and/or ovarian cancer families of French Canadian descentStephanie Cote, Suzanna L Arcand, Robert Royer, et al.
The Canadian Journal of Urology|May 5, 2006
Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancerRobert K Nam, Ants Toi, Laurence H Klotz, et al.
Pageof 55